FIELD: biotechnology, medicine, virology.
SUBSTANCE: strain "Svinka" is prepared as result of carrying out five successive directed passages of the strain "Sierra Leone" culture of Lass virus through liver of infected guinea pigs. The "Svinka" strain possesses the high virulence for guinea pigs and causes their 100% death after subcutaneous administration in the dose from 10 to 30 BFU that provides the possibility for using this strain for carrying out the laboratory evaluation of effectiveness of medicinal protection agents with respect to this pathogen.
EFFECT: valuable properties of strain.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN C/2014 OF MACHUPO VIRUS - AGENT OF BOLIVIAN HAEMORRHAGIC FEVER INTENDED FOR LABORATORY EVALUATION OF EFFECTIVENESS OF MEDICAL REMEDIES IN RESPECT OF THIS PATHOGEN | 2017 |
|
RU2699525C2 |
| EBOLA-ZAIRE VIRUS STRAIN ESMS 2020 ADAPTED FOR GUINEA PIGS, INTENDED FOR PRECLINICAL TESTING OF MEDICAL PROTECTIVE MEANS AGAINST EBOLA HEMORRHAGIC FEVER | 2020 |
|
RU2749345C1 |
| IMMUNOBIOLOGICAL AGENT FOR INDUCING IMMUNE RESPONSE AGAINST LASSA VIRUS AND METHOD FOR USING IT | 2024 |
|
RU2823965C1 |
| SMALLPOX VIRAL STRAIN GPA FOR STUDYING EFFICACY OF ANTIVIRAL PREPARATIONS in vivo AND ASSESSING REDUCTION ROUTINES UNDESIRED VACCINE REACTIONS ACCOMPANYING PRIMARY SMALLPOX VACCINATION | 2013 |
|
RU2542400C1 |
| STRAIN OF VIRUS "LASSA" FOR IMMUNOBIOLOGICAL PREPARATIONS PRODUCING | 0 |
|
SU1789560A1 |
| 0 |
|
SU1778176A1 | |
| STRAIN OF EBOL VIRUS "ZAIR K-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225439C2 |
| METHOD FOR DETERMINING ANTIGENIC DIFFERENCES OF ARENAVIRUS GENES OF ARENAVIRIDAE FAMILY | 2018 |
|
RU2729052C2 |
| EARLY DIAGNOSTIC TECHNIQUE FOR EBOLA HEMORRHAGIC FEVER IN INDIVIDUALS PRESUMABLY INFECTED WITH SUCH VIRUS | 2010 |
|
RU2450274C1 |
| ANTIVIRAL COMPOSITION | 2020 |
|
RU2751108C1 |
